GDF15 and choledocholithiasis: A case-control study observed a higher level of GDF-15 in patients with benign biliary diseases (acute cholecystitis, acute cholangitis, choledocholithiasis, and cholelithiasis), suggesting GDF-15 to be a potential biomarker in biliary diseases (Ozkan et al., 2011).